Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetics of prelingual isolated deafness and Usher syndrome in the Maghreb and Jordan: Harnessing the potential of homozygosity.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

The interpeduncular nucleus blunts the rewarding effect of nicotine.

Neuron·2025
Same author

[Foreword: Chronic diseases: Transition between adolescence to adulthood].

Medecine sciences : M/S·2021
Same author

Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety.

Neuron·2021
Same author

Next Generation Sequencing Should Be Proposed to Every Woman With "Idiopathic" Primary Ovarian Insufficiency.

Journal of the Endocrine Society·2021
Same author

Interaction of protocadherin-15 with the scaffold protein whirlin supports its anchoring of hair-bundle lateral links in cochlear hair cells.

Scientific reports·2020
Same journal

Summer highlights from EJHG.

European journal of human genetics : EJHG·2026
Same journal

Confirmation of frameshift variants in the last exon of FGFR1 as a cause of multiple epiphyseal dysplasia.

European journal of human genetics : EJHG·2026
Same journal

A changed landscape: five-year retrospective on the paradigm shift in genetic testing practices for ALS in Canada.

European journal of human genetics : EJHG·2026
Same journal

Parental and public views on genomic newborn screening: a systematic review.

European journal of human genetics : EJHG·2026
Same journal

Correction: follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: data from the PRED-IdF network.

European journal of human genetics : EJHG·2026
Same journal

Characterisation of the SMN1/2 locus using a highly specific variant caller on whole-genome sequence data from 500,000 individuals.

European journal of human genetics : EJHG·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

Kallmann syndrome.

Catherine Dodé1, Jean-Pierre Hardelin

  • 1Inserm U567, Département de Génétique et Développement, Institut Cochin, Paris, France. catherine.dode@inserm.fr

European Journal of Human Genetics : EJHG
|November 6, 2008
PubMed
Summary
This summary is machine-generated.

Kallmann syndrome (KS) is a complex genetic disorder causing hypogonadotropic hypogonadism and anosmia. Research identifies mutations in KAL1, FGFR1, FGF8, PROKR2, and PROK2, but over 70% of KS cases remain genetically unexplained.

More Related Videos

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

Related Experiment Videos

Last Updated: Jun 28, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

Area of Science:

  • Genetics
  • Endocrinology
  • Neuroscience

Background:

  • Kallmann syndrome (KS) is characterized by hypogonadotropic hypogonadism (HH) and congenital anosmia.
  • It presents as a clinically and genetically heterogeneous disorder.
  • Genetic factors are crucial in understanding KS pathogenesis.

Purpose of the Study:

  • To review the known genetic causes of Kallmann syndrome.
  • To highlight the genetic heterogeneity of KS.
  • To identify gaps in current genetic knowledge of KS.

Main Methods:

  • Literature review of genetic studies on Kallmann syndrome.
  • Analysis of gene mutations associated with different inheritance patterns (X-linked, autosomal dominant, recessive).
  • Examination of genes including KAL1, FGFR1, FGF8, PROKR2, and PROK2.

Main Results:

  • X-linked recessive KS is linked to mutations in KAL1 (anosmin-1).
  • Autosomal dominant forms involve mutations in FGFR1 or FGF8.
  • Mutations in PROKR2 and PROK2 are implicated in recessive and digenic/oligogenic KS forms.

Conclusions:

  • Several genes (KAL1, FGFR1, FGF8, PROKR2, PROK2) are associated with Kallmann syndrome.
  • A significant proportion of KS patients (over 70%) have unidentified genetic causes.
  • Further research is needed to discover novel genes contributing to KS etiology.